Search Results - "Agapova, L S"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    Small-molecule RETRA suppresses mutant p53-bearing cancer cells through a p73-dependent salvage pathway by Kravchenko, J.E, Ilyinskaya, G.V, Komarov, P.G, Agapova, L.S, Kochetkov, D.V, Strom, E, Frolova, E.I, Kovriga, I, Gudkov, A.V, Feinstein, E, Chumakov, P.M

    “…Identification of unique features of cancer cells is important for defining specific and efficient therapeutic targets. Mutant p53 is present in nearly half of…”
    Get full text
    Journal Article
  2. 2

    p53 hot-spot mutants increase tumor vascularization via ROS-mediated activation of the HIF1/VEGF-A pathway by Khromova, N.V, Kopnin, P.B, Stepanova, E.V, Agapova, L.S, Kopnin, B.P

    Published in Cancer letters (18-04-2009)
    “…Abstract The function of p53 tumor suppressor is often altered in various human tumors predominantly through missense-mutations resulting in accumulation of…”
    Get full text
    Journal Article
  3. 3
  4. 4

    P53-dependent effects of RAS oncogene on chromosome stability and cell cycle checkpoints by Agapova, L S, Ivanov, A V, Sablina, A A, Kopnin, P B, Sokova, O I, Chumakov, P M, Kopnin, B P

    Published in Oncogene (20-05-1999)
    “…Mutations activating the function of ras proto-oncogenes are often observed in human tumors. Their oncogenic potential is mainly due to permanent stimulation…”
    Get full text
    Journal Article
  5. 5

    Retroviral reporter systems for assessing the activity of stress-inducible signal transduction pathways controlled by the p53, HIF-1, and HSF-1 transcription factors by Razorenova, O V, Agapova, L S, Budanov, A V, Ivanov, A V, Strunina, S M, Chumakov, P M

    Published in Molecular biology (New York) (01-03-2005)
    “…The tumor suppressor p53, hypoxia-inducible factor 1 (HIF-1), and heat-shock factor 1 (HSF-1) are the key transcription factors involved in the stress response…”
    Get full text
    Journal Article
  6. 6

    Expression of the p53 Gene and Activation of p53-Dependent Transcription in Melanoma Cell Lines by Razorenova, O V, Agapova, L S, Chumakov, P M

    Published in Molecular biology (New York) (01-05-2005)
    “…Malignant melanoma has poor prognosis because of its high metastatic potential and resistance to chemotherapy. A possible approach to more effective therapy is…”
    Get full text
    Journal Article
  7. 7

    Transcriptional inhibition of human papilloma virus in cervical carcinoma cells reactivates functions of the tumor suppressor p53 by Kochetkov, D V, Il'inskaia, G V, Komarov, P G, Strom, E, Agapova, L S, Ivanov, A V, Budanov, A V, Frolova, E I, Chumakov, P M

    Published in Molekuliarnaia biologiia (01-05-2007)
    “…Inactivation of tumor suppressor p53 accompanies the majority of malignant diseases in humans. Restoration of p53 functions in tumor results in death of cancer…”
    Get more information
    Journal Article
  8. 8

    Transcriptional inhibition of the human papilloma virus reactivates tumor suppressor p53 in cervical carcinoma cells by Kochetkov, D V, Ilyinskaya, G V, Komarov, P G, Strom, E, Agapova, L S, Ivanov, A V, Budanov, A V, Frolova, E I, Chumakov, P M

    Published in Molecular biology (New York) (01-06-2007)
    “…Inactivation of tumor suppressor p53 accompanies the majority of human malignancies. Restoration of p53 function causes death of tumor cells and is potentially…”
    Get full text
    Journal Article
  9. 9

    Retroviral reporter systems for the assessment of activity of stress-induced signal transduction pathways controlled by p53, HIF-1 and HSF-1 transcription factors by Razorenova, O V, Agapova, L S, Budanov, A V, Ivanov, A V, Strunina, S M, Chumakov, P M

    Published in Molekuliarnaia biologiia (01-03-2005)
    “…Tumor suppressor p53, hypoxia-inducible factor 1 (HIF-1) and heat-shock factor 1 (HSF-1) are involved as the key transcription factors in cellular response to…”
    Get more information
    Journal Article
  10. 10

    HLA homozygous stem cell lines derived from human parthenogenetic blastocysts by Revazova, E S, Turovets, N A, Kochetkova, O D, Agapova, L S, Sebastian, J L, Pryzhkova, M V, Smolnikova, V I U, Kuzmichev, L N, Janus, J D

    Published in Cloning and stem cells (01-03-2008)
    “…Individual HLA homozygous parthenogenetic human stem cell (hpSC-Hhom) lines have the potential for cell-based therapy in a significant number of individuals,…”
    Get more information
    Journal Article
  11. 11

    Activation of p53-mediated cell cycle checkpoint in response to micronuclei formation by Sablina, A A, Ilyinskaya, G V, Rubtsova, S N, Agapova, L S, Chumakov, P M, Kopnin, B P

    Published in Journal of cell science (01-04-1998)
    “…Inactivation of p53 tumor-suppressor leads to genetic instability and, in particular, to accumulation of cells with abnormal numbers of chromosomes. In order…”
    Get full text
    Journal Article
  12. 12

    Induction of hyperdiploidy and chromosome breaks in LIM1215 cells expressing the exogenous mutant p53 by Agapova, L S, Turovets, N A, Ivanov, A V, Il'inskaia, G V, Chumakov, P M

    Published in Genetika (01-08-1996)
    “…The effect of modifications of p53 expression on the incidence of numerical and structural chromosome aberrations was studied. Infection of LIM1215 cells…”
    Get more information
    Journal Article
  13. 13

    p53 DOES NOT CONTROL THE SPINDLE ASSEMBLY CELL CYCLE CHECKPOINT BUT MEDIATES G1 ARREST IN RESPONSE TO DISRUPTION OF MICROTUBULE SYSTEM by Sablina, Anna A, Agapova, Larissa S, Chumakov, Peter M, Kopnin, Boris P

    Published in Cell biology international (01-05-1999)
    “…p53 plays a critical role as a tumour-suppressor in restricting the proliferation of damaged cells, thus preventing formation of genetically altered cell…”
    Get full text
    Journal Article
  14. 14

    The antioxidant function of the p53 tumor suppressor by Chumakov, Peter M, Sablina, Anna A, Budanov, Andrei V, Ilyinskaya, Galina V, Agapova, Larissa S, Kravchenko, Julia E

    Published in Nature medicine (01-12-2005)
    “…It is widely accepted that the p53 tumor suppressor restricts abnormal cells by induction of growth arrest or by triggering apoptosis. Here we show that, in…”
    Get full text
    Journal Article
  15. 15

    Experience in the production and clinical application of the cell-based medicinal product Easytense® for the repair of cartilage defects of the human knee by Zoricheva, A. S., Zvonova, E. A., Agapova, L. S., Lykova, M. S., Markova, O. A., Leonov, V. S.

    Published in Biopreparaty (01-07-2024)
    “…INTRODUCTION . The current cell-based cartilage repair methods, such as autologous chondrocyte transplantation, are not sufficiently effective, and the surgery…”
    Get full text
    Magazine Article
  16. 16

    Progress in understanding moleculr mechanisms of oncogenesis, and novel methods of tumor growth control by Agapova, L S, Kopnin, B P

    “…Malignant tumor develop from cells with distorted signaling pathways controlling proliferation, migration, viability, differentiation, and genome integrity, as…”
    Get more information
    Journal Article
  17. 17

    Chromosome changes caused by alterations of p53 expression by Agapova, L S, Ilyinskaya, G V, Turovets, N A, Ivanov, A V, Chumakov, P M, Kopnin, B P

    Published in Mutation research (05-07-1996)
    “…It has been proposed that p53 tumor-suppressor plays a key role in maintaining genome integrity in mammalian cells. We analyzed karyotype alterations in human…”
    Get more information
    Journal Article
  18. 18

    Effect of inactivating the p33ING1 tumor suppressor on the function of cell cycle "checkpoints" and genome stability by Turovets, N A, Agapova, L S, Kopnin, P B, Tulina, N M, Chumakov, P M, Kopnin, B P

    Published in Genetika (01-03-2000)
    “…Novel candidate tumor suppressor p33ING1 is known to regulate activity of the p53 protein. The effect of p33ING1 inactivation on the functioning of the cell…”
    Get more information
    Journal Article
  19. 19